DEA Moves to Deny a Minneapolis Dispensary Over Minnesota's Law, Not Anything It Did

On the morning of Friday, October 30, several agents of the Drug Enforcement Administration walked into In-Dispensary, a state-licensed cannabis store in downtown Minneapolis, and handed its owner, Mark Eide, a document about the federal registration he had applied for. It was not a certificate. It was an order to show cause, the step the DEA takes when it proposes to deny an application, and it carried the signature of Cheri Oz, the assistant administrator who runs the agency's Diversion Control Division. (S1, S2)

"They said they are giving me this because the DEA sees it as not in the public interest to let me have the medical [cannabis registration]," Eide told the Minnesota Star Tribune that day. "They said they are serving a lot of other people today with this same document." (S1)

What the order left out is what made it unusual. It did not accuse In-Dispensary of breaking a Minnesota rule, losing track of inventory or selling to someone it should not have. Every reason it gave was about Minnesota. The state lets a single license cover both medical and adult-use sales, a structure the order calls "dual-purpose," and the DEA said that license "falls outside the recent promulgated definition of 'state medical license.'" Granting a registration under it, the order said, would "bestow the imprimatur of legitimacy upon such conduct" in a way "inconsistent with the [Controlled Substances Act] as well as United States' treaty obligations." (S1, S2)

The same afternoon in Washington, the Justice Department announced that the DEA had issued its first federal registrations to more than 900 medical cannabis dispensaries. Every one of them sits in Alabama, Florida, Mississippi, South Dakota, Texas, Virginia or West Virginia. Six of those states run medical-only programs; Virginia has legalized adult-use sales but has not started licensing them. Attorney General Todd Blanche said the registrations would "help ensure broader access to chronic pain treatment." The department added a sentence that Eide's order put into practice: "State licensure alone does not automatically grant federal registration." (S3, S2)

The DEA's own waiting list shows how many businesses sit on Eide's side of that line. The agency's timely-applicant file dated October 30 holds 6,983 entries without a single company name. Counting it by state, cannabis.inc found 30 Minnesota entries, 26 of them dispensaries; 209 in Missouri, which issues what it calls comprehensive licenses for both markets; and 160 in Ohio, where every one of the 233 dispensary certificates the state lists is a dual-use certificate. California, where a combined license is common, has 771. None of those states was in Friday's batch. (S7, S10, S13)

The money at stake is the reason operators applied. For years, Section 280E of the tax code has barred businesses trafficking in Schedule I or II substances from deducting ordinary expenses, and federal registration under Schedule III is expected to change that for medical sales. Carol Moss, a cannabis attorney in Edina, Minnesota, said the DEA's reading would cut businesses in dual-license states out of that benefit wholesale. "Even if the business isn't involved in recreational cannabis, if they are just in the state they miss out on this benefit," she told the Star Tribune. (S1, S11)

Both sides can quote the rule Eide applied under. Section 1301.13(k), added by the April final rule, tells the DEA to run an expedited review for "entities holding state medical marijuana licenses." It says the Administrator "shall register an applicant" unless registration is "inconsistent with the public interest," and that, in general, an applicant complying with a state regime that has protections against diversion, recordkeeping and reporting rules, and safety and inspection measures will pass. It also says a state license "shall constitute conclusive evidence" that the applicant is authorized under state law. That is the strongest ground an applicant like Eide has: the rule pointed the DEA at the quality of a state's controls, and Minnesota has controls. (S4)

The DEA's answer starts with a definition. The April order defines a state medical marijuana license as one authorizing the licensee to manufacture, distribute or dispense cannabis "for medical purposes," and the rule states that registrations "do not authorize" anything for non-medical purposes. From there the order reasons that a license permitting adult-use sales is something else, and that dispensing for non-medical purposes is "per se diversion under the CSA." A Minnesota store, in the agency's view, cannot hold a license that authorizes what federal law calls diversion and still be a safe registrant. (S2, S4, S5)

The order did not stop at the license. Ryan Kocot, a cannabis attorney who reviewed the document, counts three independent grounds for denial: the dual-purpose license; Minnesota's path for veterans, which lets them obtain medical cannabis with veteran identification and an attestation of a qualifying diagnosis rather than a practitioner's written certification; and the state's authorization of synthetically derived cannabinoid products, which the order says remain in Schedule I. Because the grounds are independent, Kocot wrote, fixing the license question alone would not necessarily resolve the others. (S8, S2)

The DEA has offered Eide two routes. He can ask for a hearing before an administrative law judge; under 21 CFR 1301.43, a party entitled to one must file a written request within 30 days of receiving the order. Or he can submit a corrective action plan. Moss doubts the second route leads anywhere when the objection is to state law. "Even if he said 'I'm only doing medical', I don't think it would be enough because the DEA doesn't like Minnesota law," she said. (S1, S6)

An order to show cause is a proposal, not a final decision, and that distinction runs straight into the supply chain the DEA is building around its registrants. The agency's October 30 guidance extends timely-applicant status, which lets a business keep operating under its state license and trade with other timely applicants and registrants, to everyone who applied between April 28 and June 26 except those whose applications were withdrawn or denied by "a Final Order," and those "who lack the requisite state medical marijuana license." Set beside an order arguing that Minnesota's license is not a state medical license at all, that last clause raises a question the guidance does not answer: whether In-Dispensary, and the businesses that buy from or sell to it, can still count on its timely status before any final order issues. (S12, S4)

Neil Willner, a New York attorney with the cannabis firm Vicente LLP who focuses on regulatory compliance, said he had seen nothing like it since the April order. "That seems like a significant shift from how the initial April rescheduling order was written in the first place," he told the Star Tribune. "This letter is very curious and certainly troubling." (S1)

“They appear to be testing whether a state can be disqualified as a whole, rather than judging an individual applicant.”

— Neil Willner, attorney, Vicente LLP

Gillian Schauer, executive director of the Cannabis Regulators Association, which counts 45 state and territorial governments as members, said the DEA had sent orders to businesses in a wide range of states, including some that allow only medical cannabis, and that state regulators had received no notice. "Many questions remain about the implementation of the DEA registered system for medical marijuana," she said, listing how the agency will buy and resell cannabis under the order, how it will coordinate with states and what its enforcement priorities will be. Minnesota's Office of Cannabis Management said it had heard nothing from the DEA about its programs and that the letter "does not impact the state law" authorizing them. "Medical cannabis remains available to patients in the state," the office said. (S1, S2)

In Missouri the question arrived before the order did. Amy Moore, director of the state's Division of Cannabis Regulation, said on the division's podcast this month that in Missouri the line between a medical and an adult-use product "only comes into play at that moment of sale when a particular tax rate is applied," while the federal order "seems to be really organized around medical marijuana." Drew Lammert, co-founder of High Fidelity Brands and chair of the Missouri Cannabis Trade Association's government affairs committee, said medical sales are about 10 percent of his company's business. "We are excited, but there's also those questions of the unknowns," he said, "and what does that mean for the 90 percent of adult use sales out there." (S10)

California is testing a structural answer. On October 30, the same day as Eide's visit, the Department of Cannabis Control gave public notice of a rule to make permanent its emergency regulations letting retailers with both medicinal and adult-use designations split them into separate licenses, which may be issued to a different legal entity at the same premises. Comments run through December 14. Kocot is not convinced it settles anything. Separate licenses may answer the formal objection, he wrote, without satisfying the agency's broader concern about diversion when employees, storage and inventory are shared. (S9, S8)

1. Within 30 days of receiving the order: In-Dispensary's window to request a hearing under 21 CFR 1301.43, or to offer a corrective action plan.
2. Nov. 29, 2026: the DEA's deadline for timely applicants to establish supply chains limited to other timely applicants and registrants.
3. Dec. 14, 2026: public comment closes on California's rule to split combined medicinal and adult-use licenses.
4. Pending: the separate DEA proceeding on rescheduling marijuana beyond state medical programs, which the Justice Department says remains open.

The broader rescheduling case may not rescue Eide either. Kocot noted that the Minnesota order rests on more than a schedule: non-medical dispensing, patient certification and treaty obligations would all survive a wider reclassification unless the DEA rewrote its registration rules too. (S3, S8)

In-Dispensary still holds the same Minnesota license it held before the agents arrived, and the state says the DEA's letter does not change that. Eide's application is pending, and the clock on his hearing request is running. The certificate he wanted would have told the federal government which of his sales were medical. The order he got instead says the question was never about his sales. It was about the state that licensed him, and about 30 Minnesota entries on a federal list, 209 more in Missouri and 160 in Ohio that now have to decide whether to argue with that reading or wait to see who receives the next one. (S1, S7)

Keep Reading

Policy & Compliance

Hochul Ends New York's Cannabis Labor-Peace Mandate the Day the Judge Weighing It Dies

Chapter 369 repeals the 2021 union-neutrality requirement at once, but a deal with legislative leaders strips the AFL-CIO-seated wage board meant to replace it. A Brooklyn retailer's fully briefed federal challenge now waits for a new judge, and organized labor gets neither the mandate nor its replacement.

By Cannabis Inc, Editorial Staff·7 min read

Policy & Compliance

Policy in focusCannabis.Inc

A Virginia State Senator Posted That She Owned a Cannabis Store. Prosecutors Put It in the Indictment.

Sen. L. Louise Lucas, 82, and six others were charged October 14 over a Portsmouth hemp shop the FBI values at $4.5 million. State regulators had cited the store twice for THC above the legal limit, in 2023 and again in 2024. Lucas says she is being targeted.

By Cannabis Inc, Editorial Staff·8 min read